• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

最新的培养技术:破解骨髓秘密,大规模生产红细胞和血小板。

Latest culture techniques: cracking the secrets of bone marrow to mass-produce erythrocytes and platelets .

机构信息

Department of Molecular Medicine, University of Pavia, Pavia.

Department of Molecular Medicine, University of Pavia, Pavia, Italy; Department of Chemistry, Materials and Chemical Engineering G. Natta, Politecnico di Milano, Milano.

出版信息

Haematologica. 2021 Apr 1;106(4):947-957. doi: 10.3324/haematol.2020.262485.

DOI:10.3324/haematol.2020.262485
PMID:33472355
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8017859/
Abstract

Since the dawn of medicine, scientists have carefully observed, modeled and interpreted the human body to improve healthcare. At the beginning there were drawings and paintings, now there is three-dimensional modeling. Moving from two-dimensional cultures and towards complex and relevant biomaterials, tissue-engineering approaches have been developed in order to create three-dimensional functional mimics of native organs. The bone marrow represents a challenging organ to reproduce because of its structure and composition that confer it unique biochemical and mechanical features to control hematopoiesis. Reproducing the human bone marrow niche is instrumental to answer the growing demand for human erythrocytes and platelets for fundamental studies and clinical applications in transfusion medicine. In this review, we discuss the latest culture techniques and technological approaches to obtain functional platelets and erythrocytes ex vivo. This is a rapidly evolving field that will define the future of targeted therapies for thrombocytopenia and anemia, but also a long-term promise for new approaches to the understanding and cure of hematologic diseases.

摘要

自医学诞生以来,科学家们一直在仔细观察、建模和解释人体,以改善医疗保健。最初有绘画,现在有三维建模。为了创造具有天然器官三维功能的仿生物,科学家们从二维文化转向复杂相关的生物材料,开发了组织工程方法。由于骨髓的结构和组成赋予其独特的生化和机械特性来控制造血,因此骨髓是一个具有挑战性的再生器官。复制人类骨髓龛对于满足日益增长的基础研究和输血医学临床应用中对人类红细胞和血小板的需求至关重要。在这篇综述中,我们讨论了获得功能血小板和红细胞的最新培养技术和技术方法。这是一个快速发展的领域,将定义针对血小板减少症和贫血的靶向治疗的未来,但也是理解和治疗血液疾病的新方法的长期承诺。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7061/8017859/86dce8decf08/106947.fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7061/8017859/61e2b1b71d3e/106947.fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7061/8017859/fa0ba1984aef/106947.fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7061/8017859/c7201cd0d0d0/106947.fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7061/8017859/86dce8decf08/106947.fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7061/8017859/61e2b1b71d3e/106947.fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7061/8017859/fa0ba1984aef/106947.fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7061/8017859/c7201cd0d0d0/106947.fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7061/8017859/86dce8decf08/106947.fig4.jpg

相似文献

1
Latest culture techniques: cracking the secrets of bone marrow to mass-produce erythrocytes and platelets .最新的培养技术:破解骨髓秘密,大规模生产红细胞和血小板。
Haematologica. 2021 Apr 1;106(4):947-957. doi: 10.3324/haematol.2020.262485.
2
Platelet bioreactor: accelerated evolution of design and manufacture.血小板生物反应器:设计与制造的加速演进
Platelets. 2017 Jul;28(5):472-477. doi: 10.1080/09537104.2016.1265922. Epub 2017 Jan 23.
3
Inside-to-outside and back to the future of megakaryopoiesis.巨核细胞生成的由内而外与回归未来
Res Pract Thromb Haemost. 2023 May 30;7(4):100197. doi: 10.1016/j.rpth.2023.100197. eCollection 2023 May.
4
Three-Dimensional Tissue Models for Studying Ex Vivo Megakaryocytopoiesis and Platelet Production.用于研究体外巨核细胞生成和血小板产生的三维组织模型。
Methods Mol Biol. 2018;1812:177-193. doi: 10.1007/978-1-4939-8585-2_11.
5
In vitro generation of platelets: Where do we stand?血小板的体外生成:我们目前的进展如何?
Transfus Clin Biol. 2017 Sep;24(3):273-276. doi: 10.1016/j.tracli.2017.06.013. Epub 2017 Jun 29.
6
In vitro human bone marrow analog: clinical potential.体外人骨髓模拟物:临床潜力。
Regen Med. 2010 Mar;5(2):289-98. doi: 10.2217/rme.10.7.
7
The construction of high efficiency human bone marrow tissue ex vivo.高效人骨髓组织的体外构建。
J Cell Biochem. 1991 Mar;45(3):268-72. doi: 10.1002/jcb.240450308.
8
Current approaches in biomaterial-based hematopoietic stem cell niches.基于生物材料的造血干细胞龛的当前方法。
Acta Biomater. 2018 May;72:1-15. doi: 10.1016/j.actbio.2018.03.028. Epub 2018 Mar 22.
9
Traditional and Advanced Cell Cultures in Hematopoietic Stem Cell Studies.传统与先进的造血干细胞培养方法。
Cells. 2019 Dec 12;8(12):1628. doi: 10.3390/cells8121628.
10
Toward modeling the bone marrow niche using scaffold-based 3D culture systems.使用基于支架的 3D 培养系统来模拟骨髓龛。
Biomaterials. 2011 Jan;32(2):321-9. doi: 10.1016/j.biomaterials.2010.09.041. Epub 2010 Oct 16.

引用本文的文献

1
In vitro studies of human erythropoiesis using a 3D silk-based bone marrow model that generates erythroblastic islands.使用生成成红细胞岛的基于三维丝绸的骨髓模型对人类红细胞生成进行的体外研究。
Blood Adv. 2025 May 13;9(9):2192-2206. doi: 10.1182/bloodadvances.2024014905.
2
Differentiating erythroblasts adapt to mechanical stimulation by upregulation of cholesterol biosynthesis via S1P/SREBP-induced HMGCR expression.分化中的成红细胞通过鞘氨醇-1-磷酸/固醇调节元件结合蛋白诱导的3-羟基-3-甲基戊二酰辅酶A还原酶表达上调胆固醇生物合成来适应机械刺激。
Sci Rep. 2024 Dec 4;14(1):30157. doi: 10.1038/s41598-024-81746-8.
3
Heterogeneity of platelets and their responses.

本文引用的文献

1
Advances in gene therapy for hematologic disease and considerations for transfusion medicine.血液疾病的基因治疗进展及输血医学相关考虑。
Semin Hematol. 2020 Apr;57(2):83-91. doi: 10.1053/j.seminhematol.2020.07.004. Epub 2020 Jul 28.
2
Membrane budding is a major mechanism of in vivo platelet biogenesis.膜出芽是体内血小板发生的主要机制。
J Exp Med. 2020 Sep 7;217(9). doi: 10.1084/jem.20191206.
3
Effects of the COVID-19 pandemic on supply and use of blood for transfusion.新冠疫情对输血用血供应和使用的影响。
血小板的异质性及其反应。
Res Pract Thromb Haemost. 2024 Mar 1;8(2):102356. doi: 10.1016/j.rpth.2024.102356. eCollection 2024 Feb.
4
Bioprinting Soft 3D Models of Hematopoiesis using Natural Silk Fibroin-Based Bioink Efficiently Supports Platelet Differentiation.利用天然丝素蛋白基生物墨水生物打印造血 3D 模型可有效促进血小板分化。
Adv Sci (Weinh). 2024 May;11(18):e2308276. doi: 10.1002/advs.202308276. Epub 2024 Mar 21.
5
Highly efficient platelet generation in lung vasculature reproduced by microfluidics.微流控技术再现肺血管中高效的血小板生成。
Nat Commun. 2023 Jul 7;14(1):4026. doi: 10.1038/s41467-023-39598-9.
6
Inside-to-outside and back to the future of megakaryopoiesis.巨核细胞生成的由内而外与回归未来
Res Pract Thromb Haemost. 2023 May 30;7(4):100197. doi: 10.1016/j.rpth.2023.100197. eCollection 2023 May.
7
Sirtuin 6 Regulates the Activation of the ATP/Purinergic Axis in Endothelial Cells.Sirtuin 6 调节内皮细胞中 ATP/嘌呤能轴的激活。
Int J Mol Sci. 2023 Apr 4;24(7):6759. doi: 10.3390/ijms24076759.
8
Illustrated State-of-the-Art Capsules of the ISTH 2022 Congress.国际血栓与止血学会(ISTH)2022年大会的图说前沿胶囊。
Res Pract Thromb Haemost. 2022 Jul 6;6(5):e12747. doi: 10.1002/rth2.12747. eCollection 2022 Jul.
9
iPSC diversity: A key for better use and improved targeting.诱导多能干细胞的多样性:更好利用和精准靶向的关键
J Thromb Haemost. 2021 Jul;19(7):1641-1643. doi: 10.1111/jth.15328.
10
Miniaturized 3D bone marrow tissue model to assess response to Thrombopoietin-receptor agonists in patients.用于评估患者对血小板生成素受体激动剂反应的微型 3D 骨髓组织模型。
Elife. 2021 Jun 1;10:e58775. doi: 10.7554/eLife.58775.
Lancet Haematol. 2020 Oct;7(10):e756-e764. doi: 10.1016/S2352-3026(20)30186-1. Epub 2020 Jul 3.
4
Matrix Mechanosensation in the Erythroid and Megakaryocytic Lineages.基质机械感知在红系和巨核系细胞中的作用。
Cells. 2020 Apr 6;9(4):894. doi: 10.3390/cells9040894.
5
Essential Role of Patient Blood Management in a Pandemic: A Call for Action.患者血液管理在大流行中的重要作用:行动呼吁。
Anesth Analg. 2020 Jul;131(1):74-85. doi: 10.1213/ANE.0000000000004844.
6
Coronavirus Disease 2019: Coronaviruses and Blood Safety.2019 年冠状病毒病:冠状病毒与血液安全。
Transfus Med Rev. 2020 Apr;34(2):75-80. doi: 10.1016/j.tmrv.2020.02.003. Epub 2020 Feb 21.
7
iPSC-Derived Platelets Depleted of HLA Class I Are Inert to Anti-HLA Class I and Natural Killer Cell Immunity.iPSC 衍生血小板耗尽 HLA I 类是惰性的抗 HLA I 类和自然杀伤细胞免疫。
Stem Cell Reports. 2020 Jan 14;14(1):49-59. doi: 10.1016/j.stemcr.2019.11.011. Epub 2019 Dec 26.
8
Comparing the two leading erythroid lines BEL-A and HUDEP-2.比较两种主要的红系细胞系BEL-A和HUDEP-2。
Haematologica. 2020 Aug;105(8):e389-e394. doi: 10.3324/haematol.2019.229211. Epub 2019 Nov 21.
9
Large-scale in vitro production of red blood cells from human peripheral blood mononuclear cells.从人外周血单个核细胞大规模体外生产红细胞。
Blood Adv. 2019 Nov 12;3(21):3337-3350. doi: 10.1182/bloodadvances.2019000689.
10
Defective interaction of mutant calreticulin and SOCE in megakaryocytes from patients with myeloproliferative neoplasms.巨核细胞中突变钙网蛋白与 SOCE 的缺陷相互作用与骨髓增殖性肿瘤。
Blood. 2020 Jan 9;135(2):133-144. doi: 10.1182/blood.2019001103.